Home >Reviews >Pipeline shield single antiplatelet therapy aneurysmal subarachnoid haemorrhage: multicentre experience

Literature Review

Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage: multicentre experience

Background

The Pipeline embolisation Device with shield technology (PED-shield) is suggested to have reduced thrombogenicity. This reduced thrombogenicity may make it possible to use safely in the acute treatment of aneurysmal subarachnoid haemorrhage (aSAH) on single antiplatelet therapy (SAPT).

Objective

To evaluate the safety and efficacy of the off-label use of PED-shield with SAPT for the acute treatment of aSAH.

PLEASE LOG IN OR CREATE A FREE LINNC ONLINE ACCOUNT

Join now the LINNC online community!

Not registered yet? Create your 100% free LINNC online account in less than 1 minute and enjoy a full range of educational content: LIVE & recorded cases from LINNC Courses and Seminars, expert interviews, cases shared by worldwide experts, latest news from Interventional neuroradiology field and much more!

LINNC online is also an interactive platform on which you can join your peers, share comments, live chat during LINNC Masterclass or answer polls.

You already have an account:

Create your account:

Your free LINNC account will offer you access to:

A full library of LIVE cases from LINNC Course
LINNC Masterclass Replays & Lives
Cases commented by experts on various topics
Recorded Cases commented during the LINNC Course and Seminars
And much more…